Market revenue in 2021 | USD 32.7 million |
Market revenue in 2028 | USD 86.7 million |
Growth rate | 15% (CAGR from 2021 to 2028) |
Largest segment | Adventitious virus tests |
Fastest growing segment | Adventitious Virus Tests |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Adventitious Virus Tests, Antibody Production Tests, Retrovirus Tests, Specific Virus Tests, Other Tests |
Key Regions: U.S. , Japan , Canada , Australia , South Korea
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to virus safety testing services market will help companies and investors design strategic landscapes.
Adventitious virus tests was the largest segment with a revenue share of 36.39% in 2021. Horizon Databook has segmented the China virus safety testing services market based on adventitious virus tests, antibody production tests, retrovirus tests, specific virus tests, other tests covering the revenue growth of each sub-segment from 2016 to 2028.
Virus safety testing services market in China is expected to grow at a lucrative rate during the forecast period, owing to a growing pharmaceutical industry. In addition, presence of government agencies performing a primary role in regulating and monitoring biological product quality has facilitated growth opportunities for virus safety testing services.
China has a number of regulatory oversight bodies, such as the Ministry of Health (China), overseeing laboratory & experiment approval and biosafety oversight. The official body has enforced the General Biosafety Standard for Microbiology and Biomedical Laboratories to ensure biological product quality, thus providing growth opportunities for virus safety testing services in the country.
According to a survey by CPhI Worldwide, China’s biologics market is expected to be the fastest-growing one in Asia Pacific. Several companies have started establishing GMP manufacturing capabilities for the development of biopharmaceuticals, which is positively impacting the virus safety testing services market.
Horizon Databook provides a detailed overview of country-level data and insights on the China virus safety testing services market , including forecasts for subscribers. This country databook contains high-level insights into China virus safety testing services market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account